113 related articles for article (PubMed ID: 30359859)
21. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
[TBL] [Abstract][Full Text] [Related]
22. 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics.
Favor DA; Powers JJ; White AD; Fitzgerald LW; Groppi V; Serpa KA
Bioorg Med Chem Lett; 2010 Oct; 20(19):5666-9. PubMed ID: 20801650
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into the lipid and ligand regulation of serotonin receptors.
Xu P; Huang S; Zhang H; Mao C; Zhou XE; Cheng X; Simon IA; Shen DD; Yen HY; Robinson CV; Harpsøe K; Svensson B; Guo J; Jiang H; Gloriam DE; Melcher K; Jiang Y; Zhang Y; Xu HE
Nature; 2021 Apr; 592(7854):469-473. PubMed ID: 33762731
[TBL] [Abstract][Full Text] [Related]
24. Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.
Brindisi M; Butini S; Franceschini S; Brogi S; Trotta F; Ros S; Cagnotto A; Salmona M; Casagni A; Andreassi M; Saponara S; Gorelli B; Weikop P; Mikkelsen JD; Scheel-Kruger J; Sandager-Nielsen K; Novellino E; Campiani G; Gemma S
J Med Chem; 2014 Nov; 57(22):9578-97. PubMed ID: 25343529
[TBL] [Abstract][Full Text] [Related]
25. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
[TBL] [Abstract][Full Text] [Related]
26. QSAR Analysis of Multimodal Antidepressants Vortioxetine Analogs Using Physicochemical Descriptors and MLR Modeling.
Rajathei DM; Parthasarathy S; Selvaraj S
Curr Comput Aided Drug Des; 2019; 15(4):294-307. PubMed ID: 30317998
[TBL] [Abstract][Full Text] [Related]
27. 5-HT
Huang M; Kwon S; Rajagopal L; He W; Meltzer HY
Psychopharmacology (Berl); 2018 Oct; 235(10):2795-2808. PubMed ID: 30066135
[TBL] [Abstract][Full Text] [Related]
28. Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism.
Horiguchi M; Meltzer HY
Behav Brain Res; 2013 Jun; 247():158-64. PubMed ID: 23538066
[TBL] [Abstract][Full Text] [Related]
29. Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors.
Franchini S; Battisti UM; Baraldi A; Prandi A; Fossa P; Cichero E; Tait A; Sorbi C; Marucci G; Cilia A; Pirona L; Brasili L
Eur J Med Chem; 2014 Nov; 87():248-66. PubMed ID: 25261823
[TBL] [Abstract][Full Text] [Related]
30. SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
McCreary AC; Glennon JC; Ashby CR; Meltzer HY; Li Z; Reinders JH; Hesselink MB; Long SK; Herremans AH; van Stuivenberg H; Feenstra RW; Kruse CG
Neuropsychopharmacology; 2007 Jan; 32(1):78-94. PubMed ID: 16710314
[TBL] [Abstract][Full Text] [Related]
31. Identification of dual active agents targeting 5-HT1A and SERT by combinatorial virtual screening methods.
Wang P; Yang F; Yang H; Xu X; Liu D; Xue W; Zhu F
Biomed Mater Eng; 2015; 26 Suppl 1():S2233-9. PubMed ID: 26406003
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Cappelli A; Manini M; Valenti S; Castriconi F; Giuliani G; Anzini M; Brogi S; Butini S; Gemma S; Campiani G; Giorgi G; Mennuni L; Lanza M; Giordani A; Caselli G; Letari O; Makovec F
Eur J Med Chem; 2013 May; 63():85-94. PubMed ID: 23466604
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor.
Yuan S; Peng Q; Palczewski K; Vogel H; Filipek S
Angew Chem Int Ed Engl; 2016 Jul; 55(30):8661-5. PubMed ID: 27244650
[TBL] [Abstract][Full Text] [Related]
34. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.
Schreiber R; Newman-Tancredi A
Neurobiol Learn Mem; 2014 Apr; 110():72-80. PubMed ID: 24423786
[TBL] [Abstract][Full Text] [Related]
35. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
36. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
[TBL] [Abstract][Full Text] [Related]
38. The Universal 3D QSAR Model for Dopamine D
Zięba A; Żuk J; Bartuzi D; Matosiuk D; Poso A; Kaczor AA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540025
[TBL] [Abstract][Full Text] [Related]
39. Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening.
Lee JH; Cho SJ; Kim MH
Molecules; 2018 Sep; 23(10):. PubMed ID: 30257450
[TBL] [Abstract][Full Text] [Related]
40. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
